Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Share News (SYNC)

Share Price Information for Syncona (SYNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 111.00
Bid: 110.60
Ask: 111.00
Change: 1.00 (0.91%)
Spread: 0.40 (0.362%)
Open: 110.00
High: 111.20
Low: 110.00
Prev. Close: 110.00
SYNC Live PriceLast checked at -
Syncona is an Investment Trust

To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Belluscura to raise GBP5 million; React buys

Thu, 12th May 2022 19:45

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Syncona Ltd - investor in healthcare companies - portfolio company, Autolus Therapeutics PLC to present data at European Hematology Association's Congress on June 9-12. Data includes positive early safety and efficacy data from AUTO4 in T cell lymphoma, and promising early data in AUTO1/22 programme in paediatric acute lymphoblastic leukaemia, as well as AUTO1 early safety and efficacy for relapsed/refractory primary central nervous system lymphoma.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based clinical stage biopharmaceutical company - Will present data on the potential of bexmarilimab in combination with standard of care for blood cancers at the European Hematology Association's Congress. Bexmarilimab is its wholly-owned novel precision cancer immunotherapy. It targets the Clever-1 receptor, which is associated with tumour-associated macrophages. "High Clever-1 expression is associated with poor survival in certain blood cancer patients and bexmarilimab provides a novel treatment approach for these patients, downregulating Clever-1 expression and igniting an effective immune response. We look forward to the imminent start of our hematology cancer clinical trial program to further explore these promising findings," says Chief Medical Officer Marie-Louise Fjallskog.

----------

Verici Dx PLC - Tennessee-based developer of clinical diagnostics for organ transplants - Results blinded, international, multi-centre validation study for Tuteva blood test showed significantly higher Positive Predictive Value for Tuteva than currently available kidney transplant blood tests. "The results reflect the wide clinical applicability of the test for comprehensive commercial adoption in a real-world setting," Verici says.

----------

Water Intelligence PLC - London-based leak detection services - Reacquires franchise in central Texas held within American Leak Detection subsidiary for USD750,000 cash, building upon acquisition of Forth Worth, Texas franchise in January. "The group is executing this regional hub model across the United States with its more than 150 corporate and franchise locations," the company says.

----------

Graft Polymer (UK) PLC - Slovenia-based polymer modification and drug delivery systems -Is granted Hazard Analysis & Critical Control Point certificate for its R&D facility in Slovenia for GraftBio division. "The HACCP certificate will allow us to create a strong reputation in the B2C market as a manufacturer of quality and safe food supplements, selling direct to consumers over time - a more lucrative revenue stream," says Chief Executive Officer Victor Bolduev.

----------

React Group PLC - South Derbyshire, England-based cleaning, hygiene and decontamination firm - Completes acquisition of window, gutter and cladding business LaddersFree Ltd for up to GBP8.5 million. GBP4.7 million is paid in cash, with GBP1.0 million in 83.3 million new ordinary shares at 1.2 pence each. Deferred consideration of GBP1.5 million to be paid in instalments. The acquired company has a "consistent track record of organic revenue growth and profitability", React says, and will broaden its customer base, reducing dependence on reactive and ad hoc work.

----------

AEX Gold Inc - Greenland-focused gold miner - Acquires mineral exploration licences No. 2020-41 and 2021-11 covering areas in south Greenland from Orano Group for no upfront consideration but a royalty on future production. The acquisition means AEX will be the largest licence holder in region, and the third-largest in Greenland, after Anglo American PLC and Greenfield Exploration. "We are excited to be substantially increasing our exposure to strategic metals and rare earth elements across Greenland. Greenland has the potential to become a crucial supplier of these vital minerals to the Western world, and AEX intends to be a key player in this," says Chief Executive Officer Eldur Olafsson.

----------

Puma VCT 12 PLC - venture capital trust managed by Puma Investments - Announces Sunlight Education Nucleus Ltd has been acquired, in which it invested GBP2.4 million in 2017. Exit represents 3.2 times return on its equity investment.

----------

Avation PLC - Singapore-based passenger aircraft leasing company - Completes second sale of series of ex-Virgin Australia Airlines ATR72-600s to Aegean Airlines for unspecified amount. Executive Chair Jeff Chatfield says: "Avation continues to reduce its few remaining unutilised aircraft in the fleet. We anticipate zero unutilised aircraft by the end of the calendar year 2022. Sales of unutilised aircraft provide capital to rebuild in a post-pandemic recovery phase."

----------

Belluscura PLC -London-based medical device developer - Will raise GBP5 million in accelerated bookbuild via placing of new shares. Proceeds will be used to fund the purchase of raw material inventory and non-recurring costs of manufacturing and engineering, in relation to its manufacturing agreement with InnoMax Medical Technology Ltd. Dowgate Capital Ltd is acting as sole placing agent, bookrunner and broker, with SPARK Advisory Partners Ltd acting as nominated adviser.

----------

Circle Property PLC - London-based buyer, developer and manager of regional office assets in UK - Has exchanged contracts for the sale of 720 Aztec West in Bristol to Maybrook Properties Ltd. Sale price of GBP2.5 million is a 77% increase on the valuation of GBP1.4 million at the end of March last year.

----------

Clontarf Energy PLC - Dublin-headquartered oil & gas exploration and production company focused on South America and Africa - Updates on drilling for Sasanof-1 exploration well. Says Valaris MS-1 rig is anchored in Dampier outer harbour, scheduled to commence tow to Sasanof-1 location on Monday. The operator Western Gas' drilling operations dteam are deployed to field and with now onboard MS-1 rig and undertake pre-mobilisation checks. Support vessels started operations on time on Monday. Drilling operations are expected to start on May 24. Has 10% working interest in Sasanof.

----------

Molten Ventures PLC - London-based venture capital firm focused on technology companies - Says portfolio company Aiven, a Finnish software company, closes externally-led series D funding round, raising USD210 million. Valuation of Aiven now USD3 billion, a "significant uplift on earlier rounds". Molten holds interest through Earlybird Partnership. Says carrying value of its holding in Aiven will be finalised as part of its final results on June 13.

----------

Mercia Asset Management PLC - regionally focused specialist asset manager – Says Knowledge-Intensive and annual Enterprise Investment Scheme funds raise total of around GBP20 million in new capital over past year.

----------

Kefi Gold & Copper PLC - Cyprus-based gold and copper exploration and development company with projects in Ethiopia and Saudi Arabia - Says progress in Ethiopia remains on track over past month, and multi-party project financing is developing. Expects to sign umbrella financing agreement this quarter, with full construction to commence from October, at the end of the current wet season. "KEFI has been able to pivot onto a much more positive direction since December 2021 due to geopolitics, regulatory changes and exploration results. We now have three advanced projects in two countries that are now overtly pro-development - a more positive and less risky position than KEFI has confronted for many years," says Executive Chair Harry Anagnostaras-Adams.

----------

European Metals Holdings Ltd - mineral exploration and development company focused on Cinovec lithium-tin project in Czech Republic - Accepted to trade on US based OTCQX Best Market, under the codes "EMHXY", "ERPNF" and "EMHLF" from Thursday. "Trading on the OTCQX comes at a pivotal time for investors seeking to leverage the transition away from fossil fuels, with the European Union offering significant funding to accelerate change and adoption rates of electric vehicles in the region continuing to climb," says Executive Chair Keith Coughlan.

----------

Future Metals NL - Perth-based platinum exploration company - Reports wide PGM assay results from drillhole samples at 100%-owned Panton PGM Project in northern Western Australia. Highlights include 60.5 metres at 1.24 grams per tonne palladium equivalent from 0 metres. "All drill hole results returned to date have confirmed significant intercepts of mineralisation, demonstrating the strong continuity of the Panton orebody along its current 3.5km strike, and the lateral extent of mineralisation sitting outside of the chromite reefs," says Chief Executive Officer & Managing Director Jardee Kininmonth. Is targeting new mineral resource estimate release in the coming weeks.

----------

Destiny Pharma PLC - Brighton-based clinical phase biotechnology company - Says data previously reported for c. difficile infection model study is accepted for presentation at Anaerobe 2022 Conference in Seattle. Data is on the ability of non-toxigenic strain M3 to colonise the gut following antibiotics. "The relevance and impact of this study cannot be underestimated as it indicates that the clinical use of fidaxomicin to treat CDI is unlikely to affect the ability of Destiny's late-stage asset, NTCD-M3, to colonise the gut and prevent recurrence of CDI," explains Chief Scientific Officer Bill Love.

----------

Mattioli Woods PLC - Leicester, England-based asset manager - Says subsidiary Ludlow Wealth Management Group Ltd has acquired Ferguson Financial Management Ltd for an initial GBP600,000 and potential further consideration of up to GBP600,000 million dependent on the attainment of performance targets in the year after completion.

----------

Capital Metals PLC - developing eastern minerals project in Sri Lanka - Says study for project demonstrates "exceptional economics" resulting in a high margin operation, enabling a short payback period. Says the long-term price assumptions used are below current prices suggesting "even more attractive economics are feasible". Further, it says the study does not take into account any potential resource extensions, which would enable the expansion of mine life and throughput, providing even further upside.

----------

HeiQ PLC - Zurich-based materials developer - Will pay deferred considerations relating to acquisitions of RAS AG and Life Material Technologies Ltd. Will pay EUR2.6 million to RAS based on its annual performance through ordinary shares of 30 pence each in HeiQ capital. Will pay USD2.8 million to Life, settled half in cash and half in new ordinary shares. Total new shares allotted for the transactions are 3.5 million.

----------

By Elizabeth Winter; elizabethwinter@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
10 Nov 2022 21:19

TRADING UPDATES: Zambeef expects profit jump; Mobile Streams wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
10 Nov 2022 15:52

UK earnings, trading statements calendar - next 7 days

Friday 11 November 
Beazley PLCHalf Year Results
Permanent TSB Group Holdings PLCTrading Statement
TheWorks.co.uk PLCTrading Statement
Urban Logistics REIT PLCHalf Year Results
Monday 14 November 
Atalaya Mining PLCQ3 Results
Biome Technologies PLCTrading Statement
Cake Box Holdings PLCHalf Year Results
Diversified Energy Co PLCTrading Statement
HgCapital Trust PLCQ3 Results
Informa PLCTrading Statement
Kainos Group PLCHalf Year Results
MySale Group PLCFull Year Results
S4 Capital PLCQ3 Results
SRT Marine Systems PLCHalf Year Results
Totally PLCHalf Year Results
Tuesday 15 November 
AdEPT Technology Group PLCHalf Year Results
BAE Systems PLCTrading Statement
Gear4Music PLCHalf Year Results
Imperial Brands PLCFull Year Results
Land Securities Group PLCHalf Year Results
Melrose Industries PLCTrading Statement
Ninety One PLC and LtdHalf Year Results
R&Q Insurance Holdings LtdQ1 Results
Speedy Hire PLCHalf Year Results
Vesuvius PLCTrading Statement
Vodafone Group PLCHalf Year Results
Wincanton PLCHalf Year Results
Workspace Group PLCHalf Year Results
Wednesday 16 November 
Aristocrat Leisure LtdFull Year Results
British Land Co PLCHalf Year Results
Castings PLCHalf Year Results
CMC Markets PLCHalf Year Results
Enteq Technologies PLCHalf Year Results
Experian PLCHalf Year Results
Mediclinic International PLCHalf Year Results
Premier Foods PLCHalf Year Results
Renold PLCHalf Year Results
Sage Group PLCFull Year Results
Schroder Global Real Estate SecuritiesHalf Year Results
Schroder Real Estate Investment Trust LtdHalf Year Results
SSE PLCHalf Year Results
Thursday 17 November 
Burberry Group PLCHalf Year Results
Close Brothers Group PLCTrading Statement
Fuller, Smith & Turner PLCHalf Year Results
Grainger PLCFull Year Results
Great Portland Estates PLCHalf Year Results
Halma PLCHalf Year Results
Integrated Diagnostics Holdings PLCQ3 Results
Intermediate Capital Group PLCHalf Year Results
International Distributions Services PLCHalf Year Results
Investec PLC and LtdHalf Year Results
Keller Group PLCTrading Statement
Mitie Group PLCHalf Year Results
Pershing Square Holdings LtdQ3 Results
Redcentric PLCHalf Year Results
Seraphim Space Investment Trust PLCQ1 Results
Spirax-Sarco Engineering PLCTrading Statement
Syncona LtdHalf Year Results
Tyman PLCTrading Statement
Virgin Money UK PLCFull Year Results
Zytronic PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
3 Nov 2022 11:50

Syncona portfolio firm Autolus Therapeutics widens quarterly loss

(Alliance News) - Syncona Ltd on Thursday noted that its portfolio company Autolus Therapeutics PLC had widened its third quarter loss as it continued to progress its candidate pipeline.

Read more
24 Oct 2022 08:53

Syncona to acquire retinal therapy firm Applied Genetic Technologies

(Alliance News) - Syncona Ltd on Monday it will expand its retinal gene therapy pipeline with the acquisition of a Florida-based biotechnology company.

Read more
24 Oct 2022 07:42

Syncona to buy US biotech AGTC for $23.5m

(Sharecast News) - Healthcare group Syncona said on Monday that it has agreed to buy US biotechnology firm Applied Genetic Technologies Corporation (AGTC) for around $23.5m, or $0.34 per share, in cash.

Read more
16 Aug 2022 10:06

Syncona confident after Q1 market volatility

(Sharecast News) - Healthcare investor Syncona reported net assets of £1.33bn at the end of its first quarter on Tuesday, or 197.9p per share, up from £1.31bn and 194.4p per share at the end of March.

Read more
16 Aug 2022 09:15

IN BRIEF: Syncona posts slight quarterly NAV rise on foreign exchange

Syncona Ltd - London-based investor in healthcare companies - Reports small quarterly net asset value rise on gain on foreign exchange. Net asset value per share at June 30 stands at 197.7 pence per share, up 1.7% from 194.4p at March 31.

Read more
9 Aug 2022 14:18

Syncona notes half-year results and studies of Freeline and Achilles

(Alliance News) - Syncona Ltd on Tuesday noted half-year results of its investees, Freeline Therapeutics Holdings PLC and Achilles Therapeutics PLC.

Read more
26 Jul 2022 15:57

UK shareholder meetings calendar - next 7 days

Wednesday 27 July 
Allied Minds PLCAGM
Caledonia Investments PLCAGM
De La Rue PLCAGM
FirstGroup PLCAGM
James Cropper PLCAGM
JPMorgan Japan Small Cap Growth & Income PLCAGM
Mode Global Holdings PLCAGM
Montanaro UK Smaller Cos Investment Trust PLCAGM
Motorpoint Group PLCAGM
Shield Therapeutics PLCAGM
Tatton Asset Management PLCAGM
Thursday 28 July 
B&M European Value Retail SAAGM
Braemar Shipping Services PLCAGM
CMC Markets PLCAGM
CMC Markets PLCGM re proposed related party transaction
CYBA PLCAGM
De La Rue PLCAGM
discoverIE Group PLCAGM
Eight Capital Partners PLCAGM
Eurasia Mining PLCAGM
GB Group PLCAGM
Global Smaller Companies Trust PLCAGM
Graft Polymer (UK) PLCAGM
Ingenta PLCAGM
Mediclinic International PLCAGM
Octopus Renewables Infrastructure Trust PLCGM re investing in offshore wind farms in core focus
Oxford Instruments PLCAGM
RentGuarantor Holdings PLCAGM
Tate & Lyle PLCAGM
Ted Baker PLCAGM
Friday 29 July 
Eneraqua Technologies PLCAGM
Global Ports Holding PLCGM re elections of Ajini and Iosifakis as directors
Palace Capital PLCAGM
ProCook Group PLCAGM
Record PLCAGM
Rogue Baron PLCAGM
Sirius Real Estate LtdAGM
Standard Chartered PLCGM re approving HY announcement, interim dividend
Monday 1 August 
Cranswick PLCAGM
Tuesday 2 August 
Caffyns PLCAGM
Syncona LtdAGM
Tanfield Group PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
11 Jul 2022 08:21

Syncona investee Freeline's gene therapy for haemophilia B tolerated

(Alliance News) - Syncona Ltd on Monday said investee Freeline Therapeutics Holdings PLC has presented partial safety and efficacy data from a phase I/II dose confirmation trial for FLT180a, a gene therapy for haemophilia B.

Read more
16 Jun 2022 10:12

Syncona records slight increase in net asset value, skips dividend

(Alliance News) - Syncona Ltd on Thursday reported a slight increase in net asset value, but a lower total return, as the value of its holdings fell due to market volatility, as the firm skipped its dividend again.

Read more
16 Jun 2022 07:27

Syncona reports flat year-end net assets

(Sharecast News) - Healthcare investment company Syncona reported flat year-end net assets of £1.31bn in its final results on Thursday.

Read more
10 Jun 2022 14:42

IN BRIEF: Syncona portfolio company sees "encouraging" early data

Syncona Ltd - London-based investor in healthcare companies - Announces that its portfolio company, Autolus Therapeutics PLC, has published new clinical data across multiple programmes. Autolus reports "positive" early safety and efficacy data from Auto4 in patients with T cell lymphoma and "encouraging" early safety and efficacy data from Auto1/22 in paediatric acute lymphoblastic leukaemia.

Read more
9 Jun 2022 15:55

UK earnings, trading statements calendar - next 7 days

Friday 10 June 
Industrials REIT LtdFull Year Results
Monday 13 June 
Augmentum Fintech PLCFull Year Results
Molten Ventures PLCFull Year Results
Sirius Real Estate LtdFull Year Results
Tuesday 14 June 
Ashtead Group PLCFull Year Results
Bellway PLCTrading Statement
CML Microsystems PLCFull Year Results
Crest Nicholson Holdings PLCHalf Year Results
discoverIE Group PLCFull Year Results
Driver Group PLCHalf Year Results
Ferguson PLCQ3 Results
FirstGroup PLCFull Year Results
iomart Group PLCFull Year Results
LoopUp Group PLCTrading Statement
Montanaro UK Smaller Cos Investment Trust PLCFull Year Results
OnTheMarket PLCFull Year Results
Oxford Instruments PLCFull Year Results
Paragon Banking Group PLCHalf Year Results
Renalytix PLCTrading Statement
Vianet Group PLCFull Year Results
Wednesday 15 June 
AO World PLCFull Year Results
Bloomsbury Publishing PLCFull Year Results
Castings PLCFull Year Results
Custodian REIT PLCFull Year Results
Allied Minds PLCFull Year Results
Tatton Asset Management PLCFull Year Results
FireAngel Safety Technology Group PLCTrading Statement
Idox PLCHalf Year Results
IGas Energy PLCTrading Statement
JPMorgan European Discovery Trust PLCFull Year Results
Motorpoint Group PLCFull Year Results
SCS Group PLCTrading Statement
Severfield PLCFull Year Results
WH Smith PLCQ3 Trading Update
Whitbread PLCTrading Statement
Thursday 16 June 
Best of the Best PLCFull Year Results
boohoo Group PLCTrading Statement
CareTech Holdings PLCHalf Year Results
Filtronic PLCTrading Statement
GB Group PLCFull Year Results
Halfords Group PLCFull Year Results
Halma PLCFull Year Results
JLEN Environmental Assets Group LtdFull Year Results
Lindsell Train Investment Trust PLCFull Year Results
Momentum Multi-Asset Value Trust PLCFull Year Results
Mountview Estates PLCFull Year Results
N Brown Group PLCTrading Statement
NextEnergy Solar Fund LtdFull Year Results
River & Mercantile UK Micro Cap Investment Co LtdHalf Year Results
S4 Capital PLCTrading Statement
Syncona LtdFull Year Results
Volex PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
18 May 2022 13:01

Syncona invests USD54 million in SwanBio Therapeutics funding round

(Alliance News) - Syncona Ltd said on Wednesday it invested USD54 million in neurological disorder-focused gene therapy company SwanBio Therapeutics' Series B financing round.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.